The European School of Haematology (ESH), shared on X (Twitter) insights from the 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024):

“Dr Lina Benajiba delivered an outstanding presentation revealing the transformation paths of MPNs, complemented by a captivating model.”

Lina Benajiba is a physician scientist, hematologist & clinical pharmacologist at the St. Louis Hospital (Hôpital Saint-Louis AP-HP), Assistant Professor at the INSERM Institute of Health and Medical Research, in Paris France.

Her research is focused on identification and targeting of extrinsic regulators of myeloid malignancies.

Lina Benajiba / leukemiarf.org

The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024)

The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024) is held in Mandelieu-La Napoule, France, from April 26 to April 28.

The conference is co-chaired by Jean-Jacques Kiladjian, Ross Levine, and Jyoti Nangalia.

The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024)

The European School of Haematology (ESH), established in 1985, is a non-profit organization dedicated to fostering education and sharing advanced knowledge in hematology and associated fields across Europe.

ESH offers both in-person and online training opportunities, and its conferences showcase the latest scientific advancements and research in hematology.

OncoDaily is a leading global media platform in oncology, committed to being the voice of oncology.